Float Short %

14.09

Margin Of Safety %

Put/Call OI Ratio

0.7

EPS Next Q Diff

0.06

EPS Last/This Y

1.25

EPS This/Next Y

0.9

Price

39.02

Target Price

54.25

Analyst Recom

1.38

Performance Q

12.08

Relative Volume

0.8

Beta

0.78

Ticker: HRMY

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2024-12-19	HRMY	33.87	0.71	3.29	2843
2024-12-20	HRMY	34.24	0.71	0.00	2842
2024-12-23	HRMY	35	0.85	0.31	2121
2024-12-24	HRMY	34.06	0.83	0.23	2178
2024-12-26	HRMY	34.74	0.79	0.00	2269
2024-12-27	HRMY	34.22	0.72	0.39	2389
2024-12-30	HRMY	34.03	0.71	0.00	2443
2024-12-31	HRMY	34.45	0.70	0.00	2463
2025-01-02	HRMY	34.81	0.70	1.00	2463
2025-01-03	HRMY	34.78	0.70	0.00	2467
2025-01-06	HRMY	34.47	0.70	2.76	2475
2025-01-07	HRMY	35.21	0.69	0.22	2479
2025-01-08	HRMY	34.53	0.68	0.28	2521
2025-01-09	HRMY	34.53	0.68	0.28	2521
2025-01-10	HRMY	33.87	0.69	0.08	2541
2025-01-13	HRMY	36.44	0.67	0.03	2591
2025-01-14	HRMY	36.42	0.72	0.00	2502
2025-01-15	HRMY	36.92	0.72	0.14	2496
2025-01-16	HRMY	38.38	0.70	0.00	2524
2025-01-17	HRMY	39.05	0.70	1.81	2529
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2024-12-19	HRMY	33.85	13.6	156.3	3.42
2024-12-20	HRMY	34.25	13.6	156.3	3.42
2024-12-23	HRMY	34.95	13.6	159.9	3.42
2024-12-24	HRMY	34.06	13.6	142.3	3.42
2024-12-26	HRMY	34.72	13.6	159.8	3.42
2024-12-27	HRMY	34.20	13.6	146.4	3.42
2024-12-30	HRMY	34.02	13.6	150.2	3.42
2024-12-31	HRMY	34.45	13.6	156.7	3.42
2025-01-02	HRMY	34.83	13.6	157.0	3.42
2025-01-03	HRMY	34.75	13.6	151.3	3.42
2025-01-06	HRMY	34.45	13.6	148.5	3.42
2025-01-07	HRMY	35.20	13.6	160.1	3.42
2025-01-08	HRMY	34.53	13.6	145.0	3.42
2025-01-09	HRMY	34.53	13.6	152.2	3.42
2025-01-10	HRMY	33.83	13.6	144.3	3.42
2025-01-13	HRMY	36.42	13.6	181.9	3.42
2025-01-14	HRMY	36.39	13.6	151.5	3.42
2025-01-15	HRMY	36.93	13.6	157.7	3.42
2025-01-16	HRMY	38.50	13.6	168.7	3.42
2025-01-17	HRMY	39.02	16.6	156.9	3.42
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2024-12-19	HRMY	-35.89	-10.80	13.45
2024-12-20	HRMY	-35.89	-10.80	13.45
2024-12-23	HRMY	-35.62	-10.80	13.45
2024-12-24	HRMY	-35.62	-10.80	13.45
2024-12-26	HRMY	-36.48	-10.80	13.44
2024-12-27	HRMY	-35.89	-10.80	13.44
2024-12-30	HRMY	-36.24	-10.80	13.44
2024-12-31	HRMY	-36.24	-10.80	13.44
2025-01-02	HRMY	-35.65	-10.80	13.44
2025-01-03	HRMY	-35.89	-10.80	13.44
2025-01-06	HRMY	-35.92	-10.80	13.44
2025-01-07	HRMY	-35.92	-10.80	13.44
2025-01-08	HRMY	-35.89	-10.80	13.44
2025-01-09	HRMY	-35.89	-10.80	13.44
2025-01-10	HRMY	-35.89	-10.80	13.44
2025-01-13	HRMY	-35.89	-10.81	14.09
2025-01-14	HRMY	-35.89	-10.81	14.09
2025-01-15	HRMY	-35.91	-10.81	14.09
2025-01-16	HRMY	-35.91	-10.81	14.09
2025-01-17	HRMY	-35.93	-10.81	14.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.79

Avg. EPS Est. Current Quarter

0.83

Avg. EPS Est. Next Quarter

0.85

Insider Transactions

-35.93

Institutional Transactions

-10.81

Beta

0.78

Average Sales Estimate Current Quarter

198

Average Sales Estimate Next Quarter

183

Fair Value

49.64

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

37.2

Max Drawdown 5-Year %

Target Price

54.25

P/E

18.49

Forward P/E

11.7

PEG

0.8

P/S

3.27

P/B

3.73

P/Free Cash Flow

10.11

EPS

2.11

Average EPS Est. Cur. Y

3.42

EPS Next Y. (Est.)

4.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.98

Relative Volume

0.8

Return on Equity vs Sector %

1.5

Return on Equity vs Industry %

14.1

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.41

EBIT Estimation

156.9

Harmony Biosciences Holdings, I

Sector: Healthcare

Industry: Biotechnology

Employees: 246

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

stock quote shares HRMY – Harmony Biosciences Holdings, Inc. Stock Price stock today

news today HRMY – Harmony Biosciences Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch HRMY – Harmony Biosciences Holdings, Inc. yahoo finance google finance

stock history HRMY – Harmony Biosciences Holdings, Inc. invest stock market

stock prices HRMY premarket after hours

ticker HRMY fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: HRMY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y